{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:10:22Z","timestamp":1756293022338,"version":"3.44.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,27]]},"DOI":"10.7759\/cureus.91092","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:46:23Z","timestamp":1756291583000},"source":"Crossref","is-referenced-by-count":0,"title":["Coronary Microvascular Dysfunction and Risk of Cardiovascular Events in Type 2 Diabetes Without Obstructive Coronary Artery Disease (CAD): A Prospective Study"],"prefix":"10.7759","author":[{"given":"Umair","family":"Abrar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marium Nadeem","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafaq","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Wakil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Azhar Ghauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariya Qudsia","family":"Khanam Sherwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihtisham","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rameez","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.09.040","article-title":"Prevalence and prevention of cardiovascular disease and diabetes mellitus","volume":"113","author":"Balakumar P","year":"2016","unstructured":"Balakumar P, Maung-U K, Jagadeesh G. Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res. 2016, 113:600-9. 10.1016\/j.phrs.2016.09.040","journal-title":"Pharmacol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-05325-3_28-1","article-title":"Global burden of diabetes mellitus","author":"Arokiasamy P","year":"2021","unstructured":"Arokiasamy P, Salvi S, Selvamani Y. Global burden of diabetes mellitus. Handbook of Global Health. Haring R, Kickbusch I, Ganten D, Moeti M (ed): Springer, Cham; 2021. 1-44. 10.1007\/978-3-030-05325-3_28-1"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15070942","article-title":"Myocardial infarction with nonobstructive coronary arteries (MINOCA): current insights into pathophysiology, diagnosis, and management","volume":"15","author":"Tognola C","year":"2025","unstructured":"Tognola C, Maloberti A, Varrenti M, Mazzone P, Giannattasio C, Guarracini F. Myocardial infarction with nonobstructive coronary arteries (MINOCA): current insights into pathophysiology, diagnosis, and management. Diagnostics (Basel). 2025, 15:10.3390\/diagnostics15070942","journal-title":"Diagnostics (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-21-0848","article-title":"Pathophysiology of coronary microvascular dysfunction","volume":"86","author":"Crea F","year":"2022","unstructured":"Crea F, Montone RA, Rinaldi R. Pathophysiology of coronary microvascular dysfunction. Circ J. 2022, 86:1319-28. 10.1253\/circj.CJ-21-0848","journal-title":"Circ J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.900191","article-title":"Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management","volume":"121","author":"Lanza GA","year":"2010","unstructured":"Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation. 2010, 121:2317-25. 10.1161\/CIRCULATIONAHA.109.900191","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092880","article-title":"Coronary microvascular dysfunction","volume":"9","author":"Vancheri F","year":"2020","unstructured":"Vancheri F, Longo G, Vancheri S, Henein M. Coronary microvascular dysfunction. J Clin Med. 2020, 9:10.3390\/jcm9092880","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092274","article-title":"Coronary microvascular dysfunction in diabetes mellitus: pathogenetic mechanisms and potential therapeutic options","volume":"10","author":"Salvatore T","year":"2022","unstructured":"Salvatore T, Galiero R, Caturano A, et al.. Coronary microvascular dysfunction in diabetes mellitus: pathogenetic mechanisms and potential therapeutic options. Biomedicines. 2022, 10:10.3390\/biomedicines10092274","journal-title":"Biomedicines"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000002971","article-title":"Heart failure and microvascular dysfunction: an in-depth review of mechanisms, diagnostic strategies, and innovative therapies","volume":"87","author":"Singh A","year":"2025","unstructured":"Singh A, Ashraf S, Irfan H, et al.. Heart failure and microvascular dysfunction: an in-depth review of mechanisms, diagnostic strategies, and innovative therapies. Ann Med Surg (Lond). 2025, 87:616-26. 10.1097\/MS9.0000000000002971","journal-title":"Ann Med Surg (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01347","article-title":"Microvascular dysfunction in heart failure with preserved ejection fraction","volume":"10","author":"D'Amario D","year":"2019","unstructured":"D'Amario D, Migliaro S, Borovac JA, et al.. Microvascular dysfunction in heart failure with preserved ejection fraction. Front Physiol. 2019, 10:1347. 10.3389\/fphys.2019.01347","journal-title":"Front Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz339","article-title":"Diagnosis of coronary microvascular dysfunction in the clinic","volume":"116","author":"Ong P","year":"2020","unstructured":"Ong P, Safdar B, Seitz A, Hubert A, Beltrame JF, Prescott E. Diagnosis of coronary microvascular dysfunction in the clinic. Cardiovasc Res. 2020, 116:841-55. 10.1093\/cvr\/cvz339","journal-title":"Cardiovasc Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-017-9625-4","article-title":"Assessment of myocardial blood flow and coronary flow reserve with positron emission tomography in ischemic heart disease: current state and future directions","volume":"22","author":"Al Badarin F","year":"2017","unstructured":"Al Badarin F, Aljizeeri A, Almasoudi F, Al-Mallah MH. Assessment of myocardial blood flow and coronary flow reserve with positron emission tomography in ischemic heart disease: current state and future directions. Heart Fail Rev. 2017, 22:441-53. 10.1007\/s10741-017-9625-4","journal-title":"Heart Fail Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-315669","article-title":"Cardiovascular magnetic resonance imaging: emerging techniques and applications","volume":"107","author":"Chowdhary A","year":"2021","unstructured":"Chowdhary A, Garg P, Das A, Nazir MS, Plein S. Cardiovascular magnetic resonance imaging: emerging techniques and applications. Heart. 2021, 107:697-704. 10.1136\/heartjnl-2019-315669","journal-title":"Heart"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.027","article-title":"Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria","volume":"50","author":"Cortigiani L","year":"2007","unstructured":"Cortigiani L, Rigo F, Gherardi S, Sicari R, Galderisi M, Bovenzi F, Picano E. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol. 2007, 50:1354-61. 10.1016\/j.jacc.2007.06.027","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab775","article-title":"Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis","volume":"43","author":"Kelshiker MA","year":"2022","unstructured":"Kelshiker MA, Seligman H, Howard JP, et al.. Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis. Eur Heart J. 2022, 43:1582-93. 10.1093\/eurheartj\/ehab775","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-16-1002","article-title":"Coronary microvascular dysfunction\u2015epidemiology, pathogenesis, prognosis, diagnosis, risk factors and therapy","volume":"81","author":"Chen C","year":"2016","unstructured":"Chen C, Wei J, AlBadri A, Zarrini P, Bairey Merz CN. Coronary microvascular dysfunction\u2015epidemiology, pathogenesis, prognosis, diagnosis, risk factors and therapy. Circ J. 2016, 81:3-11. 10.1253\/circj.CJ-16-1002","journal-title":"Circ J"},{"key":"ref16","article-title":"Evaluation of coronary microvascular dysfunction in long-standing asymptomatic diabetic patients with 13N-NH3 cardiac PET","volume":"60","author":"Lukose T","year":"2019","unstructured":"Lukose T, Sood A, Mittal B, Barwad P, Dutta P. Evaluation of coronary microvascular dysfunction in long-standing asymptomatic diabetic patients with 13N-NH3 cardiac PET. J Nucl Med. 2019, 60:1446.","journal-title":"J Nucl Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4244\/EIJY15M03_09","article-title":"Coronary microvascular function in patients with type 2 diabetes mellitus","volume":"11","author":"Leung M","year":"2016","unstructured":"Leung M, Leung DY. Coronary microvascular function in patients with type 2 diabetes mellitus. EuroIntervention. 2016, 11:1111-7. 10.4244\/EIJY15M03_09","journal-title":"EuroIntervention"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.050427","article-title":"Improved cardiac risk assessment with noninvasive measures of coronary flow reserve","volume":"124","author":"Murthy VL","year":"2011","unstructured":"Murthy VL, Naya M, Foster CR, et al.. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011, 124:2215-24. 10.1161\/CIRCULATIONAHA.111.050427","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.12.005","article-title":"Effect of liraglutide on body weight and microvascular function in non-diabetic overweight women with coronary microvascular dysfunction","volume":"283","author":"Suhrs HE","year":"2019","unstructured":"Suhrs HE, Raft KF, Bov\u00e9 K, Madsbad S, Holst JJ, Zander M, Prescott E. Effect of liraglutide on body weight and microvascular function in non-diabetic overweight women with coronary microvascular dysfunction. Int J Cardiol. 2019, 283:28-34. 10.1016\/j.ijcard.2018.12.005","journal-title":"Int J Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240722","article-title":"Comprehensive treatment of microvascular angina in overweight women - a randomized controlled pilot trial","volume":"15","author":"Bove KB","year":"2020","unstructured":"Bove KB, Nilsson M, Pedersen LR, Mikkelsen N, Suhrs HE, Astrup A, Prescott E. Comprehensive treatment of microvascular angina in overweight women - a randomized controlled pilot trial. PLoS One. 2020, 15:e0240722. 10.1371\/journal.pone.0240722","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/0300060516675504","article-title":"Coronary microvascular dysfunction in diabetes mellitus","volume":"45","author":"Kibel A","year":"2017","unstructured":"Kibel A, Selthofer-Relatic K, Drenjancevic I, Bacun T, Bosnjak I, Kibel D, Gros M. Coronary microvascular dysfunction in diabetes mellitus. J Int Med Res. 2017, 45:1901-29. 10.1177\/0300060516675504","journal-title":"J Int Med Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa025","article-title":"Microvascular dysfunction in diabetes mellitus and cardiometabolic disease","volume":"42","author":"Horton WB","year":"2021","unstructured":"Horton WB, Barrett EJ. Microvascular dysfunction in diabetes mellitus and cardiometabolic disease. Endocr Rev. 2021, 42:29-55. 10.1210\/endrev\/bnaa025","journal-title":"Endocr Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jev012","article-title":"Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes","volume":"16","author":"Majmudar MD","year":"2015","unstructured":"Majmudar MD, Murthy VL, Shah RV, et al.. Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. Eur Heart J Cardiovasc Imaging. 2015, 16:900-9. 10.1093\/ehjci\/jev012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.1825","article-title":"Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"6","author":"Rush CJ","year":"2021","unstructured":"Rush CJ, Berry C, Oldroyd KG, et al.. Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. JAMA Cardiol. 2021, 6:1130-43. 10.1001\/jamacardio.2021.1825","journal-title":"JAMA Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01653-y","article-title":"Prognostic value of coronary microvascular dysfunction assessed by coronary angiography-derived index of microcirculatory resistance in diabetic patients with chronic coronary syndrome","volume":"21","author":"Zhang W","year":"2022","unstructured":"Zhang W, Singh S, Liu L, et al.. Prognostic value of coronary microvascular dysfunction assessed by coronary angiography-derived index of microcirculatory resistance in diabetic patients with chronic coronary syndrome. Cardiovasc Diabetol. 2022, 21:222. 10.1186\/s12933-022-01653-y","journal-title":"Cardiovasc Diabetol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.31083\/RCM25757","article-title":"Coronary microvascular dysfunction: insights on prognosis and future perspectives","volume":"26","author":"Gurgoglione FL","year":"2025","unstructured":"Gurgoglione FL, Benatti G, Denegri A, et al.. Coronary microvascular dysfunction: insights on prognosis and future perspectives. Rev Cardiovasc Med. 2025, 26:25757. 10.31083\/RCM25757","journal-title":"Rev Cardiovasc Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/397102-coronary-microvascular-dysfunction-and-risk-of-cardiovascular-events-in-type-2-diabetes-without-obstructive-coronary-artery-disease-cad-a-prospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:46:24Z","timestamp":1756291584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/397102-coronary-microvascular-dysfunction-and-risk-of-cardiovascular-events-in-type-2-diabetes-without-obstructive-coronary-artery-disease-cad-a-prospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.91092","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,27]]}}}